Notice of Change to Page Limits for Attachments to PAR-18-595, "Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required)"

---

Notice Number: NOT-AR-18-016

Key Dates
Release Date: February 08, 2018

Related Announcements
PAR-18-595

Issued by
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

The purpose of this Notice is to correct the statement about page limits for attachments in the following section of PAR-18-595 "Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required)”.
The following is detailed information about this correction:
Part 2, Full Text Announcement
Section IV, Application and Submission Information
2. Content and Form of Application Submission
PHS Human Subjects and Clinical Trials Information

The following language is corrected in this FOA:
Currently reads:
There is no page limit for these attachments, by including irrelevant information that belongs in another section of the application.
Modified to read:
There is no page limit for these attachments, but applicants should not include unnecessary information.

All other aspects of this FOA remain unchanged.